Moderna, Inc. (ETR:0QF)
22.15
-0.93 (-4.01%)
At close: Aug 25, 2025, 5:30 PM CET
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
€451,882
Profits / Employee
€426,190
Market Cap
8.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,800 | 200 | 3.57% |
Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
Dec 31, 2020 | 1,300 | 470 | 56.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
Moderna News
- 2 days ago - Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga
- 2 days ago - 30 Stocks That Could Rally 30% or More - Kiplinger
- 5 days ago - Moderna Stock Is Trading Higher Friday: What's Going On? - Benzinga
- 5 days ago - Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Wallstreet:Online
- 5 days ago - Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Accesswire
- 6 days ago - Moderna to Present at Upcoming Conferences in September 2025 - Accesswire
- 6 days ago - Moderna to Present at Upcoming Conferences in September 2025 - Wallstreet:Online
- 12 days ago - Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - Seeking Alpha